0958 ET -- Bristol Myers Squibb is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The drugmaker has agreed to buy radiopharmaceutical therapeutics company RayzeBio for $4.1 billion. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)

(END) Dow Jones Newswires

December 26, 2023 10:13 ET (15:13 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
RayzeBio (NASDAQ:RYZB)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos RayzeBio.
RayzeBio (NASDAQ:RYZB)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos RayzeBio.